Table 4.
Factors Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid (N) Antibody Level at the Time of First N Antibody–Positive Measurement (September–October 2020 or March–April 2021) Among 57 Participants in the AGEhIV Coronavirus Disease 2019 Substudy
| Factor | Univariable Analysis | Multivariable Analysisa | ||
|---|---|---|---|---|
| Coefficient (95% CI) | P Value | Coefficient (95% CI) | P Value | |
| HIV status | ||||
| HIV negative | Reference | .53 | Reference | .25 |
| HIV positive | 2.03 (−4.46 to 8.52) | 3.67 (−2.66 to 10.00) | ||
| Self-reported feverb | ||||
| No | Reference | .005 | Reference | .003 |
| 9.73 (3.39–16.06) | ||||
| Yes | 9.07 (2.82– 15.33) | |||
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus.
Values represent regression coefficients with 95% confidence interval, adjusted for HIV status and reported fever.
In the 6 months prior to the first positive severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody test.